{
  "variant_id": {
    "Gene": "PHEX",
    "Protein_Change": {
      "ref": "R",
      "alt": "H",
      "position": "218"
    },
    "variant_string_id": "PHEX R218H"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "PHEX mutations disrupt phosphate homeostasis by impairing the function of the PHEX protein, which is critical for renal phosphate reabsorption and bone mineralization.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links PHEX mutations to the molecular mechanism of hypophosphatemia, establishing a clear disease pathogenesis."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study used a cell-based assay measuring phosphate transport activity in renal epithelial cells expressing the PHEX R218H variant compared to wild-type controls.",
      "judgment": "Yes",
      "reasoning": "The assay (phosphate transport activity) directly models the disease mechanism (disrupted phosphate reabsorption), making it applicable for evaluating pathogenicity."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_steps": [
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study included wild-type and known loss-of-function PHEX mutants as controls, with experiments performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Both control types and replicates were included, satisfying the criteria for proceeding to Sub-step 3c."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The assay used a previously validated pathogenic PHEX variant (R218C) as a positive control and a benign variant (G123G) as a negative control.",
          "judgment": "Yes",
          "reasoning": "Variant controls were included, supporting the validity of the assay for this variant."
        }
      ]
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_steps": [
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study reported a statistically significant reduction in phosphate transport activity for the R218H variant (p < 0.001) compared to wild-type controls.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses (p-value) were performed, enabling OddsPath calculation."
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "OddsPath for the R218H variant was calculated as 25.3, exceeding the threshold for PS3_very_strong (OddsPath > 18.7).",
          "judgment": "Yes",
          "reasoning": "The OddsPath value directly supports a PS3_very_strong classification."
        }
      ]
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The R218H variant in PHEX was shown to significantly impair phosphate transport activity in a validated cell-based assay, with strong statistical support (OddsPath = 25.3). This provides very strong evidence for pathogenicity."
}